4.7 Article

Adiponectin, A-FABP and FGF-19 Levels in Women with Early Diagnosed Gestational Diabetes

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth

Meng-Nan Yang et al.

Summary: This study found that FGF19 is not associated with glucose homeostasis in newborns of GDM mothers. However, cord plasma FGF19 concentrations were positively correlated with birth weight and length in females, suggesting a sex-dimorphic role of FGF19 in fetal growth. Further studies are needed to validate these findings and explore the underlying mechanisms.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Biochemistry & Molecular Biology

Adiponectin as a Potential Biomarker for Pregnancy Disorders

Carmen Pheiffer et al.

Summary: Adiponectin is a hormone derived from adipocytes that plays a crucial role in energy balance by increasing insulin sensitivity. Research suggests that decreased adiponectin levels may be linked to metabolic disorders like obesity and type 2 diabetes, making it a potential biomarker for pregnancy complications. Identifying maternal factors that predict pregnancy outcomes could help with early detection of high-risk pregnancies and prevention of complications for mother and child.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Endocrinology & Metabolism

Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control Study

Maryam Mosavat et al.

Summary: The study found that adipocytokines AFABP and chemerin were associated with an increased risk of gestational diabetes and were related to insulin resistance, body mass index, and inflammation in pregnant women diagnosed with GDM. However, SPARC was not associated with GDM.

JOURNAL OF DIABETES RESEARCH (2021)

Review Medicine, General & Internal

Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?

Lore Raets et al.

Summary: The incidence of gestational diabetes mellitus (GDM) is increasing worldwide, and screening and treatment in early pregnancy still lack consensus. Observational studies show varying results in detecting GDM early, with ongoing large RCTs to determine appropriate strategies and benefits. There is also limited evidence on the sensitivity of HbA1c in early pregnancy, requiring further research.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Nutrition & Dietetics

Adipose tissue function in healthy pregnancy, gestational diabetes mellitus and pre-eclampsia

Cara Trivett et al.

Summary: Gestational diabetes mellitus and pre-eclampsia are common pregnancy disorders with implications for both maternal and infant health, and are associated with obesity. Limited understanding exists regarding the role of adipose tissue and adipocyte biology in the pathogenesis of these conditions.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2021)

Article Endocrinology & Metabolism

Risk of Gestational Diabetes Mellitus in relation to Plasma Concentrations of Fatty Acid-Binding Protein 4: A Nested Case-Control Study in China

Chuyao Jin et al.

Summary: The study found that elevated plasma FABP4 levels in the first and second trimesters of pregnancy were positively associated with insulin resistance and increased risk of gestational diabetes mellitus (GDM). Therefore, FABP4 may serve as a potential marker for predicting women at high risk of developing GDM.

JOURNAL OF DIABETES RESEARCH (2021)

Review Endocrinology & Metabolism

The role of serum adipokine levels in preeclampsia: A systematic review

Georgios Daskalakis et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Article Medicine, Research & Experimental

Circulating levels of selected adipokines in women with gestational diabetes and type 2 diabetes

David Karasek et al.

JOURNAL OF APPLIED BIOMEDICINE (2020)

Article Biochemistry & Molecular Biology

Adipocytokines are not associated with gestational diabetes mellitus but with pregnancy status

Thomas Ebert et al.

CYTOKINE (2020)

Review Biochemistry & Molecular Biology

Circulating FABP4, nesfatin-1, and osteocalcin concentrations in women with gestational diabetes mellitus: a meta-analysis

Jianran Sun et al.

LIPIDS IN HEALTH AND DISEASE (2020)

Review Medicine, General & Internal

Role of the Fatty Acid Binding Proteins in Cardiovascular Diseases: A Systematic Review

Hien C. Nguyen et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Endocrinology & Metabolism

Decreased placental and muscular expression of the fibroblast growth factor 19 in gestational diabetes mellitus

Dongyu Wang et al.

JOURNAL OF DIABETES INVESTIGATION (2019)

Review Biochemistry & Molecular Biology

Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application

Dicky Struik et al.

CURRENT OPINION IN LIPIDOLOGY (2019)

Review Peripheral Vascular Disease

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases

Masato Furuhashi

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)

Article Medicine, General & Internal

FABP4 in Gestational Diabetes-Association between Mothers and Offspring

Jolanta Patro-Malysza et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Obstetrics & Gynecology

First-Trimester Serum Fatty Acid-Binding Protein 4 and Subsequent Gestational Diabetes Mellitus

Wen-Jun Tu et al.

OBSTETRICS AND GYNECOLOGY (2017)

Article Medical Laboratory Technology

Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study

Ida Naslund Thagaard et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)

Article Endocrinology & Metabolism

First-Trimester Fasting Hyperglycemia and Adverse Pregnancy Outcomes

Shlomit Riskin-Mashiah et al.

DIABETES CARE (2009)

Article Endocrinology & Metabolism

Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus

Susan Kralisch et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)